Item request has been placed!
×
Item request cannot be made.
×
Processing Request
Late Onset of Primary Hemophagocytic Lymphohistiocytosis (HLH) with a Novel Constellation of Compound Heterozygosity Involving Two Missense Variants in the PRF1 Gene.
Item request has been placed!
×
Item request cannot be made.
×
Processing Request
- Author(s): Stadermann, Alina1 (AUTHOR) ; Haar, Markus2 (AUTHOR); Riecke, Armin1 (AUTHOR) ; Mayer, Thomas1 (AUTHOR); Neumann, Christian1 (AUTHOR); Bauer, Arthur1 (AUTHOR); Schulz, Ansgar3 (AUTHOR); Nagarathinam, Kumar4 (AUTHOR); Gebauer, Niklas5 (AUTHOR); Böhm, Svea6,7 (AUTHOR); Groß, Miriam6 (AUTHOR); Grunert, Michael8,9 (AUTHOR) ; Müller, Matthias1 (AUTHOR) ; Witte, Hanno1,5 (AUTHOR)
- Source:
International Journal of Molecular Sciences. Mar2024, Vol. 25 Issue 5, p2762. 10p.
- Subject Terms:
- Additional Information
- Abstract:
Hemophagocytic lymphohistiocytosis (HLH) is a rare but in most cases life-threatening immune-mediated disease of the hematopoietic system frequently associated with hematologic neoplasms. Here, we report on a case in which we detected a novel constellation of two missense variants affecting the PRF1 gene, leading to de novo primary HLH. Diagnostics included a comprehensive clinical work-up and standard methods of hematopathology as well as extended molecular genomics based on polymerase chain reaction (PCR) reactions and the calculation of three-dimensional molecule reconstructions of PRF1. Subsequently, a comprehensive review of the literature was performed, which showed that this compound heterozygosity has not been previously described. The patient was a 20-year-old female. Molecular diagnostics revealed two heterozygous missense variants in the PRF1 gene (A91V and R104C) on exon 2. Apart from the finding of two inconclusive genetic variants, all clinical criteria defined by the HLH study group of Histiocyte Society were met at initial presentation. The final diagnosis was made in cooperation with the Consortium of German HLH—reference centers. Here, chemotherapy did not lead to sufficient sustained disease control. Therefore, the decision for allogenic hematopoietic stem cell transplantation (alloHSCT) was made. Hitherto, the duration of response was 6 months. Due to severe and unmanageable hepatic graft-versus-host disease (GvHD), the patient died. We report on a novel constellation of a compound heterozygosity containing two missense variants on exon 2 of the PRF1 gene. To the authors' best knowledge, this is the first presentation of a primary HLH case harboring this genomic constellation with late-onset clinical manifestation. [ABSTRACT FROM AUTHOR]
- Abstract:
Copyright of International Journal of Molecular Sciences is the property of MDPI and its content may not be copied or emailed to multiple sites or posted to a listserv without the copyright holder's express written permission. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract. (Copyright applies to all Abstracts.)
No Comments.